A narrative review in the Future Healthcare Journal argues the mouth's 700-species bacterial community has been structurally excluded from medicine, despite strong links to type 2 diabetes, cardiovascular disease, and preterm birth, and weaker, associative links to Alzheimer's and cancer.
A novel polysaccharide purified from black wood-ear mushroom (Auricularia heimuer) protected mice from acetaminophen-induced liver injury, but antibiotic depletion of gut bacteria erased the effect and fecal transplants from treated mice reproduced it, showing the gut microbiota is mechanistically required. The likely driver is a microbial metabolite, trigonelline, acting through the AMPK/GSK3β and Nrf2/HO-1 pathways. The work is mouse-only with small groups.
Researchers built GutPath, a single-cell and spatial atlas of over 500,000 mouse gut cells across six infections, uncovering a previously unknown enterocyte state that clusters around Yersinia-induced immune lesions and appears driven by STAT1/STAT3/IL-18 signaling. The work is mouse-only with small group sizes, and the cell-lesion link is correlational, not causally tested.
A new mouse study finds that an extract of the herb Senecio scandens eases allergic rhinitis symptoms, partly by reshaping gut bacteria and raising levels of the gut byproduct butyrate, which independently calmed inflamed nasal cells in the lab.
Lab grown gut communities show that Segatella copri, the bacterium behind plant-rich-diet gut profiles, cannot outcompete Bacteroides type bacteria on fiber alone. It needs E. coli or a related microbe as a partner, even when the right fiber is present.
A new mouse study found that combining defatted rice bran with inulin, two dietary fibers, raised gut Bifidobacteria and the short-chain fatty acid butyrate more than either fiber alone, and modestly improved exploratory behavior in middle-aged female mice. The effect has only been shown in a small group of mice, and most memory and motor tests showed no difference between groups.
A systematic review of 21 clinical trials examined whether probiotics, prebiotics and synbiotics can improve cholesterol and triglyceride levels in people with dyslipidaemia, finding suggestive but inconclusive evidence.
A new mechanistic study finds that propionate, a short-chain fatty acid made by gut bacteria, drives CD8+ T-cells into colorectal tumors and strengthens immunotherapy, even in the microsatellite stable tumors that usually resist these drugs. The evidence spans human blood and tumor samples plus two mouse models, though human testing of the mechanism has not yet begun.
Researchers scraped the tongue coating of 62 older adults, 31 with Alzheimer's and 31 without, and found a distinct bacterial and chemical signature in the Alzheimer's group, centered on a fat-metabolism pathway that also showed up disrupted in their spinal fluid.
A new critical review of 143 studies examines Lachnospiraceae, a common family of gut bacteria linked to immune regulation and cancer immunotherapy response. The mechanisms are well established in rodents, but most human evidence is correlational, and only one strain has cleared FDA review and real placebo-controlled trials, for blood sugar control, not cancer.
